Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Emerging Roles of RNA Methylation in Development
Mengke Wang, Chun‐Chun Gao, Yun‐Gui Yang
Accounts of Chemical Research (2023) Vol. 56, Iss. 23, pp. 3417-3427
Closed Access | Times Cited: 21
Targeting methionine metabolism in cancer: opportunities and challenges
Peng Bin, Chuanlong Wang, Hangchao Zhang, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 395-405
Closed Access | Times Cited: 11
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation
Xingyan Xu, Xuefen Zhuang, Haowei Yu, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 2151-2166
Open Access | Times Cited: 6
The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9‐Mediated Splicing of NFATc4
Shuting Yu, ZhiYong Sun, Tiantian Ju, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 6
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner
Zi‐Qi Zheng, Feizhi Lin, Baiwei Zhao, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Insight into the roles of lactylation in macrophages: functions and clinical implications
Min Shu, Dingci Lu, Ziyi Zhu, et al.
Clinical Science (2025) Vol. 139, Iss. 02, pp. 151-169
Closed Access
The Mechanism and Latest Progress of m6A Methylation in the Progression of Pancreatic Cancer
Zehao Liu, Peng Ma, Ying He, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 1187-1201
Open Access
Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer
Siyue Zhang, Ning Zhang, Tong Wan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Mechanistic study of METTL3 inducing ferroptosis to promote cervical cancer progression through mediating m6A modification of COTE-1
Luyao Min, Fu‐Chun Huo, Zhiman Zhu, et al.
Cellular Signalling (2025), pp. 111649-111649
Closed Access
LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications
Manzhi Gao, Wentian Zhang, Xinxin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1453-1453
Open Access
METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway
Runkun Liu, Guozhi Yin, Hang Tuo, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 5
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Fibroblast-like synoviocytes-derived exosomal circFTO deteriorates rheumatoid arthritis by enhancing N6-methyladenosine modification of SOX9 in chondrocytes
Guoqing Li, Yuxuan Fang, Nan Xu, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy
Jun-Xiao Shi, Zhichao Zhang, Hao-zan Yin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation
Rongfang Gong, Z. H. Zhang, Tung‐Tien Sun, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer
Yuanqian Cai, Yingzhe Wang, Bingjie Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116241-116241
Closed Access | Times Cited: 3
ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host
Lili Feng, Min Li, Jie Ma, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 3, pp. 913-920
Open Access | Times Cited: 3
Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi
Cell chemical biology (2024) Vol. 31, Iss. 8, pp. 1422-1446
Closed Access | Times Cited: 3
METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression
Rulin Zhang, Rui Yang, Zhuodeng Huang, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22595-e22595
Open Access | Times Cited: 8
IGF2BP2-related modification patterns in pancreatic cancer: A machine learning-driven approach towards personalized treatment
Dongjie Chen, Longjun Zang, Yanling Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28243-e28243
Open Access | Times Cited: 2
Identification of m6A-related lncRNAs LINC02471 and DOCK9-DT as potential biomarkers for thyroid cancer
Dengwang Chen, Hongyuan Zhao, Zhanwen Guo, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112050-112050
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top